Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FCWWP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,484
Award facts
- Contract value 100% obligated
- $71,484.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $71,484.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose-2 pen/mL pharmaceutical supply on May 16, 2025, with completion required by May 19, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds significant responsibility as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's SPE2DX prime contract enables broad delivery of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs. This delivery order for Cosentyx, a specialized immunosuppressant medication, exemplifies AmerisourceBergen's role in supplying specialized pharmaceutical commodities to Defense Health Agency and other government healthcare systems operating under the DLA's pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FCWWP?
SPE2DB25FCWWP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 16, 2025.
How much is contract SPE2DB25FCWWP worth?
The government has obligated $71,484 on SPE2DB25FCWWP.
Is contract SPE2DB25FCWWP an order under another contract?
Yes. SPE2DB25FCWWP is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCWWP competed?
The extent of competition for SPE2DB25FCWWP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award